The voltage-sensing domain of neuronal Kv7 channels as a molecular target for epilepsy-causing mutations and anticonvulsants.

Francesco Miceli, Maria Virginia Soldovieri, Fabio Arturo Iannotti, Vincenzo Barrese, Paolo Ambrosino, Maria Martire, Maria Roberta Cilio, Maurizio Taglialatela

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)


Understanding the molecular mechanisms underlying voltage-dependent gating in voltage-gated ion channels (VGICs) has been a major effort over the last decades. In recent years, changes in the gating process have emerged as common denominators for several genetically determined channelopathies affecting heart rhythm (arrhythmias), neuronal excitability (epilepsy, pain), or skeletal muscle contraction (periodic paralysis). Moreover, gating changes appear as the main molecular mechanism by which several natural toxins from a variety of species affect ion channel function. In this work, we describe the pathophysiological and pharmacological relevance of the gating process in voltage-gated K(+) channels encoded by the K(v)7 gene family. After reviewing the current knowledge on the molecular mechanisms and on the structural models of voltage-dependent gating in VGICs, we describe the physiological relevance of these channels, with particular emphasis on those formed by K(v)7.2-K(v)7.5 subunits having a well-established role in controlling neuronal excitability in humans. In fact, genetically determined alterations in K(v)7.2 and K(v)7.3 genes are responsible for benign familial neonatal convulsions, a rare seizure disorder affecting newborns, and the pharmacological activation of K(v)7.2/3 channels can exert antiepileptic activity in humans. Both mutation-triggered channel dysfunction and drug-induced channel activation can occur by impeding or facilitating, respectively, channel sensitivity to membrane voltage and can affect overlapping molecular sites within the voltage-sensing domain of these channels. Thus, understanding the molecular steps involved in voltage-sensing in K(v)7 channels will allow to better define the pathogenesis of rare human epilepsy, and to design innovative pharmacological strategies for the treatment of epilepsies and, possibly, other human diseases characterized by neuronal hyperexcitability.
Original languageEnglish
Pages (from-to)1-15
Number of pages15
JournalFrontiers in Pharmacology of ion channel and channelopaties
Publication statusPublished - 2011


  • Kv7 channels
  • Potassium channels
  • anticonvulsant drugs
  • epilepsy
  • gating
  • neuronal excitability
  • retigabine
  • voltage-sensing


Dive into the research topics of 'The voltage-sensing domain of neuronal Kv7 channels as a molecular target for epilepsy-causing mutations and anticonvulsants.'. Together they form a unique fingerprint.

Cite this